Upgrade to SI Premium - Free Trial

Goldman Sachs Upgrades Medtronic, Inc. (MDT) to Neutral

November 19, 2025 3:17 AM
Goldman Sachs analyst David Roman upgraded Medtronic, Inc. (NYSE: MDT) from Sell to Neutral with a price target of $111.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades

Next Articles